IKBKG and neoplasm: Abrogation of the conventional IKK/NF-κB signaling by deleting inhibitor of NF-κB kinase regulatory subunit gamma (Ikbkg), which encodes NEMO, through genetic manipulation did not significantly affect the development of the primary tumor, but resulted in substantially reduced metastasis and prolonged survival of the mice.